Task Force Report on Cautionary Statements in OTC Advertisements
- 期刊名称Annals of Pharmacotherapy
- 作者Day, R. L.; Hansten, P. D.; Williams, R. L.; Cupit, G. C.
- 卷第14卷
- 期第5期
- 印刷ISSN1060-0280
- 电子ISSN1542-6270
- 文件大小4957.63KB
- 发表时间1980-05-01
- DOI10.1177/106002808001400506
- 页码358-370
Reserpine and breast cancerDankward Kodlin; Nancy McCarthy · 1978
RESERPINE, PROLACTIN, ALLERGY, AND BREAST CANCERSkutsch, GillianM. · The Lancet · 1974
RESERPINE AND BREAST CANCERKEWITZ, H · 1976
RESERPINE AND BREAST CANCER1974
RESERPINE AND BREAST CANCERInpharma Weekly · 1982
Reserpine and Breast CancerLabarthe, Darwin R. · JAMA · 1980
Reserpine and Breast Cancer: A PerspectiveJick, Hershel · JAMA: The Journal of the American Medical Association · 1975
Infliximab Treatment of SarcoidosisSerio, Ryan N · The Annals of Pharmacotherapy · 2003
Community Pharmacy Services in PortugalCosta, S.; Santos, C.; Silveira, J. · Annals of Pharmacotherapy · 2006
Bioavailability of DigoxinFrancke, D. E · Annals of Pharmacotherapy · 2006
Nelfinavir mesylate: a protease inhibitorPai, V. · Annals of Pharmacotherapy · 1999
Pharmacoeconomics: Historical PerspectiveBootman, J L. · Annals of Pharmacotherapy · 2006
Handbook of Anticancer Pharmacokinetics and PharmacodynamicsGwilt, P. R · Annals of Pharmacotherapy · 2004
Mifepristone: Less Obvious Adverse EffectsRudd, Gene · The Annals of Pharmacotherapy · 2001
Pharmaceutical Care, 2nd EditionJones, Mark · The Annals of Pharmacotherapy · 2003